Hemodynamic Response to Exercise Training in Heart Failure With Reduced Ejection Fraction Patients

被引:0
|
作者
Kirsch, Marine [1 ]
Iliou, Marie-Christine [2 ]
Vitiello, Damien [1 ]
机构
[1] Univ Paris Cite, Inst Sci Sport Sante Paris I3SP, URP 3625, F-75015 Paris, France
[2] Hop Celton, APHP Ctr, Dept Cardiac Rehabil & Secondary Prevent, Issy Les Moulineaux, France
关键词
Heart failure; Cardiac rehabilitation; Exercise training; Hemodynamics; Individual response; CHRONOTROPIC INCOMPETENCE; IMPEDANCE CARDIOGRAPHY; CARDIAC REHABILITATION; CAPACITY; MEN; MORTALITY; FITNESS; DETERMINANTS; PERFORMANCE; IMPROVEMENT;
D O I
10.14740/cr1591
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Supervised exercise training decreases total and cardiac mortality and increases quality of life of heart failure with reduced ejection fraction (HFrEF) patients. However, response to training is variable from one patient to another and factors responsible for a positive response to training remain unclear. The aims of the study were to compare cardiac hemodynamic changes after an exercise training program in responders (R) versus non -responders (NR) HFrEF patients, and to compare different discriminators used to assess response to training. Methods: Seventy-six HFrEF patients (86% males, 57 +/- 12 years) completed an exercise training program for 4 weeks. Patients underwent cardiopulmonary exercise testing (CPET) on a cycle ergometer before and after training. Cardiac hemodynamics were measured by impedance cardiography during CPET. The R and NR groups were classified using the median change in peak oxygen uptake (VO2peak). Results: There were statistically significant differences in VO2peak (+35% vs. -1%, P < 0.0001) and in peaks of ventilation (+30% vs. +2%, P < 0.0001), cardiac output (COpeak) (+25% vs. +4%, P < 0.01), systolic blood pressure (+12% vs. +2%, P < 0.05), diastolic blood pressure (+9% vs. +4%, P < 0.05) and heart rate (+8% vs. +1%, P < 0.01) between R and NR after the training program. VO2peak was the best discriminator between R and NR (receiver operating characteristic (ROC) area under the curve (AUC) = 0.83, P < 0.0001), followed by COpeak (ROC AUC = 0.77, P < 0.0001). Conclusion: VO2peak is the best discriminator between HFrEF R and NR patients after the training program. Responders showed improvements in peak hemodynamic parameters. These results pave the way for other studies to determine how the individualization of exercise training programs and peak hemodynamic parameters potentially linked to a better positive response status.
引用
收藏
页码:18 / 28
页数:11
相关论文
共 50 条
  • [41] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [42] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [43] Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    Armstrong, Paul W.
    Pieske, Burkert
    Anstrom, Kevin J.
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Jia, Gang
    McNulty, Steven E.
    Patel, Mahesh J.
    Roessig, Lothar
    Koglin, Joerg
    O'Connor, Christopher M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1883 - 1893
  • [44] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [45] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Volpe, Massimo
    Santolamazza, Caterina
    Tocci, Giuliano
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [46] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [47] Cells in Patients with Heart Failure with Reduced Ejection Fraction
    Lopes, Jose
    Teixeira, Manuel
    Cavalcante, Suiane
    Gouveia, Marisol
    Duarte, Ana
    Ferreira, Miriam
    Simoes, Maria I.
    Conceicao, Maria
    Ribeiro, Ilda P.
    Goncalves, Ana C.
    Schmidt, Cristine
    de Jesus, Bruno Bernardes
    Almeida, Ramiro
    Viamonte, Sofia
    Santos, Mario
    Ribeiro, Fernando
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (03) : 289 - 295
  • [48] Benzodiazepines in Patients with Heart Failure and Reduced Ejection Fraction
    Chuang, Chi
    Hsiao, Fu-Chih
    Cheng, Yu-Wen
    Lin, Chia-Pin
    Tung, Ying-Chang
    Wu, Chia-Tung
    Chen, Ching-Yen
    Chu, Pao-Hsien
    ACTA CARDIOLOGICA SINICA, 2022, 38 (05) : 573 - 583
  • [49] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Borghi, Claudio
    Cicero, Arrigo F. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 972
  • [50] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Massimo Volpe
    Caterina Santolamazza
    Giuliano Tocci
    Current Cardiology Reports, 2016, 18